Do inflammatory cytokines push hair follicles into the telogen (resting) phase and cause inflammatory hair shedding?

The relationship between systemic inflammation and hair loss is well-established through mechanistic research and clinical observations. Inflammatory cytokines serve as the primary chemical messengers that disrupt the hair follicle's normal growth cycle, leading to diffuse shedding known as telogen effluvium.

Mechanisms of Follicular Disruption

Inflammatory cytokines, particularly Interferon-gamma (IFN-γ), Tumor Necrosis Factor-alpha (TNF-α), and Transforming Growth Factor-beta (TGF-β), act as potent signaling molecules that terminate the active growth phase (anagen) of the hair follicle.

• Immune Privilege Collapse: IFN-γ triggers a collapse of the "immune privilege" naturally found in the hair follicle bulb. By upregulating MHC class I/II molecules, it recruits CD8+ T cells to the follicle, leading to lymphocytic infiltration that halts cell proliferation and induces follicular dystrophy.
• Apoptotic Signaling: TNF-α activates NF-κB pathways and promotes apoptotic (programmed cell death) signaling in the hair matrix cells. This accelerated cell death forces the follicle to skip the remainder of its growth cycle and enter the regression (catagen) and resting (telogen) phases prematurely.
• The JAK-STAT Pathway: IFN-γ signaling specifically utilizes the JAK1/2 and STAT1/3 pathways to upregulate genes that maintain follicle quiescence. This effectively "locks" the follicle in the resting phase and inhibits its transition back to the growth phase.

Clinical Evidence and Hair Shedding

Systemic inflammation results in a synchronized shift of a large percentage of hair follicles into the telogen phase, leading to noticeable shedding approximately 2–3 months after the initial inflammatory event.

• Inflammatory Markers: Research, particularly in post-viral contexts like COVID-19, has demonstrated that the severity of hair shedding correlates significantly with systemic inflammatory markers. Elevated levels of C-reactive protein (CRP >1.90 mg/L) and IL-1β (>5 ng/L) are strong predictors of telogen effluvium.
• Transition Timing: While cytokines like IL-1β and IL-6 immediately disrupt follicle biology, the physical shedding of the hair shaft (exogen) typically occurs several weeks to months later, once the follicle has fully transitioned into the telogen phase.
• Reversibility: The use of JAK inhibitors in clinical settings has been shown to reverse cytokine-mediated quiescence, promoting hair regrowth by allowing follicles to exit the resting phase and re-enter anagen.

Bottom line

Inflammatory cytokines are primary drivers of inflammatory hair shedding. They function by collapsing follicular immune privilege and activating apoptotic pathways, which forces hair follicles into a premature and prolonged resting (telogen) phase. This process is clinically evidenced by the strong correlation between systemic inflammatory markers and the onset of telogen effluvium.